Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
NNoile-Immune Biotech Inc. logo
4893TSE Growth

Noile-Immune Biotech Inc.

ノイルイミューン・バイオテック Yahoo Finance

Recent & upcoming events

Aug 13
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
May 14
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 24
Shareholder meeting 21:00
Shareholders' meeting
Venue: 赤坂インターシティAIR ４F（東京都港区赤坂１丁目８番１号） Details
Add to Google Calendar
Feb 13
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 13
Earnings 1:00 approx.
Q3 earnings announcement (scheduled)
Add to Google Calendar
2027
Feb 12
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
May 14
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Aug 13
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥5M YoY -34.1%
Operating income ¥-797M margin -15945.1%
Net income ¥-794M YoY —
EPS ¥-18 EPS is sourced from a different data provider than net income (for reference)
P/E —
ROE —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q1FY26 Q1
Revenue ¥303M¥3M¥3M¥0——
Operating income ¥-14M¥-280M¥-339M¥-343M——
Net income ¥-17M¥-280M¥-340M¥-343M——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2023–2025）

事業法人 35.3%国内機関 3.1%海外機関 8.5%個人 21.1%未開示 32%202320242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

武田薬品工業株式会社 18.8%武田薬品工業株式会社株式会社鶴亀 16.5%株式会社鶴亀玉田　耕治 8.7%玉田　耕治KOREA SECURITIES D 8.5%KOREA SECURITIES DEPOSITORY-SAMSUNG（常任代理人　シティバンク、エヌ・エイ東京支店）瀬戸　恭子 3.9%瀬戸　恭子大和日台バイオベンチャー投資事業有限 3.1%大和日台バイオベンチャー投資事業有限責任組合荻原　弘子 2.3%荻原　弘子佐古田　幸美 2.3%佐古田　幸美和田　聡 2.2%和田　聡石崎　秀信 1.8%石崎　秀信202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
武田薬品工業株式会社 8,119,800 18.8% Yuho (EDINET)
株式会社鶴亀 7,159,550 16.5% Yuho (EDINET)
玉田 耕治 3,750,000 8.7% Yuho (EDINET)
KOREA SECURITIES DEPOSITORY-SAMSUNG 3,678,720 8.5% Yuho (EDINET)
瀬戸 恭子 1,700,000 3.9% Yuho (EDINET)
大和日台バイオベンチャー投資事業有限責任組合 1,349,200 3.1% Yuho (EDINET)
荻原 弘子 1,000,000 2.3% Yuho (EDINET)
佐古田 幸美 1,000,000 2.3% Yuho (EDINET)
和田 聡 956,900 2.2% Yuho (EDINET)
石崎 秀信 760,000 1.8% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

2/9 4 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✗ Positive ROA ROA -19.8%
— Positive operating cash flow No data
✓ ROA improved YoY -20.1% → -19.8%
— Operating CF exceeds net income (accrual quality) No data
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 98.4% → 98.0%
— Current ratio improved No data
✓ No dilution (shares outstanding did not increase) 43,301,765 → 43,301,765
— Gross margin improved No data
✗ Asset turnover improved 0.00× → 0.00×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio —
Current ratio —
Years of positive operating CF —
Payout ratio —
Latest fiscal year result Loss (net loss ¥794M)

Performance history

Last 10 years
0億円2億円3億円5億円6億円 FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
Revenue 0.971.016.263.170.080.05
Operating income -6.04-7.68-1.06-7.75-10.7-7.97
Ordinary income ———-11.3-9.62-7.91
Net income -6.37-7.95-3.87-11.3-9.64-7.94
Total assets ———57.848.040.1
Equity ———56.947.339.3

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY20FY21FY22FY23FY24FY25
EPS ¥-16¥-19¥-10¥-27¥-22¥-18
ROE ——————
Operating CF ——————
Investing CF ——————
Financing CF ——————
FCF ——————

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

Debt-free ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data